Cargando…

Familial Hypercholesterolemia Genetic Variations and Long-Term Cardiovascular Outcomes in Patients with Hypercholesterolemia Who Underwent Coronary Angiography

Background: Familial hypercholesterolemia (FH) has been associated with early coronary artery disease (CAD) and increased risk of atherosclerotic cardiovascular disease. However, the prevalence of FH and its long-term outcomes in a CAD-high-risk cohort, defined as patients with hypercholesteremia wh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Wen-Jane, Chuang, Han-Ni, Chen, Yi-Ming, Liang, Kae-Woei, Tung, Hsin, Chen, Jun-Peng, Lee, I-Te, Wang, Jun-Sing, Lin, Ching-Heng, Lin, Hsueh-Ju, Sheu, Wayne Huey-Herng, Lee, Wen-Lieng, Hsiao, Tzu-Hung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8467756/ https://www.ncbi.nlm.nih.gov/pubmed/34573395 http://dx.doi.org/10.3390/genes12091413

Ejemplares similares

Prevalence and prognosis of genetically proven familial hypercholesterolemia in subjects with coronary artery disease and reduced ejection fraction
por: Lee, Wen-Jane, et al.
Publicado: (2023)

Performance of HbA(1c) and Fasting Plasma Glucose in Screening for Diabetes in Patients Undergoing Coronary Angiography
por: Wang, Jun-Sing, et al.
Publicado: (2013)

Association Between Serum Adipsin Levels and Insulin Resistance in Subjects With Various Degrees of Glucose Intolerance
por: Wang, Jun-Sing, et al.
Publicado: (2018)

Characterization of familial hypercholesterolemia in Taiwanese ischemic stroke patients
por: Tung, Hsin, et al.
Publicado: (2021)

Synergistic effect of renalase and chronic kidney disease on endothelin-1 in patients with coronary artery disease ‒ a cross-sectional study
por: Li, Yu-Hsuan, et al.
Publicado: (2018)

Regaining body weight after weight reduction further increases pulse wave velocity in obese men with metabolic syndrome
por: Liang, Kae-Woei, et al.
Publicado: (2018)

Post-challenge insulin concentration is useful for differentiating between coronary artery disease and cardiac syndrome X in subjects without known diabetes mellitus
por: Liang, Kae-Woei, et al.
Publicado: (2017)

Value of Chromosome 9p21 Polymorphism for Prediction of Cardiovascular Mortality in Han Chinese Without Coronary Lesions: An Observational Study
por: Lee, I-Te, et al.
Publicado: (2015)

Genetically confirmed familial hypercholesterolemia in outpatients with hypercholesterolemia
por: Wang, Xu, et al.
Publicado: (2018)

Correlation between reduction of superior interventricular groove epicardial fat thickness and improvement of insulin resistance after weight loss in obese men
por: Liang, Kae-Woei, et al.
Publicado: (2014)

Brain-derived neurotrophic factor, but not body weight, correlated with a reduction in depression scale scores in men with metabolic syndrome: a prospective weight-reduction study
por: Lee, I-Te, et al.
Publicado: (2014)

Circulating adipokines and insulin resistance in subjects with combined cardiac and metabolic syndrome X
por: Liang, Kae-Woei, et al.
Publicado: (2015)

Genetics of Hypercholesterolemia: Comparison Between Familial Hypercholesterolemia and Hypercholesterolemia Nonrelated to LDL Receptor
por: Jarauta, Estíbaliz, et al.
Publicado: (2020)

Prevalence of genetically defined familial hypercholesterolemia and the impact on acute myocardial infarction in Taiwanese population: A hospital-based study
por: Chen, Yen-Ju, et al.
Publicado: (2022)

Relationship between body weight and the increment in serum brain-derived neurotrophic factor after oral glucose challenge in men with obesity and metabolic syndrome: A prospective study
por: Lee, I-Te, et al.
Publicado: (2016)

The promising novel therapies for familial hypercholesterolemia
por: Chen, Ruoyu, et al.
Publicado: (2022)

Plasma aryl hydrocarbon receptor associated with epicardial adipose tissue in men: a cross-sectional study
por: Cheng, Yu-Cheng, et al.
Publicado: (2023)

The dawn phenomenon in type 2 diabetes: its association with glucose excursions and changes after oral glucose-lowering drugs
por: Wang, Jun-Sing, et al.
Publicado: (2021)

Prevalence and Treatment of Familial Hypercholesterolemia and Severe Hypercholesterolemia in Older Adults in Ontario, Canada
por: Akioyamen, Leo E., et al.
Publicado: (2022)

The synergistic effect of inflammation and metabolic syndrome on intraocular pressure: A cross-sectional study
por: Lee, I-Te, et al.
Publicado: (2017)

Familial Hypercholesterolemia
por: Baruah, Dibya Kumar
Publicado: (2021)

Serum brain-derived neurotrophic factor predicting reduction in pulse pressure after a one-hour rest in nurses working night shifts
por: Lee, I-Te, et al.
Publicado: (2018)

Serum Renalase Levels Are Predicted by Brain-Derived Neurotrophic Factor and Associated with Cardiovascular Events and Mortality after Percutaneous Coronary Intervention
por: Lee, I-Te, et al.
Publicado: (2018)

The Chromosome 9p21 Variant Not Predicting Long-Term Cardiovascular Mortality in Chinese with Established Coronary Artery Disease: An Eleven-Year Follow-Up Study
por: Lee, I-Te, et al.
Publicado: (2014)

Familial hypercholesterolemia in very young myocardial infarction
por: Li, Sha, et al.
Publicado: (2018)

Genetics, Screening, and Treatment of Familial Hypercholesterolemia: Experience Gained From the Implementation of the Vietnam Familial Hypercholesterolemia Registry
por: Truong, Thanh-Huong, et al.
Publicado: (2020)

The Clinical Importance of Differentiating Monogenic Familial Hypercholesterolemia from Polygenic Hypercholesterolemia
por: Tandirerung, Fistra Janrio
Publicado: (2022)

Polygenic risk score for hypercholesterolemia in a Brazilian familial hypercholesterolemia cohort
por: Lima, Isabella Ramos, et al.
Publicado: (2022)

Influence of hypercholesterolemia and diabetes on long-term outcome in patients with stable coronary artery disease receiving percutaneous coronary intervention
por: Lin, Mao-Jen, et al.
Publicado: (2019)

Improvement of oxidative stress status by lipoprotein apheresis in Chinese patients with familial hypercholesterolemia
por: Wen, Jun, et al.
Publicado: (2019)

Homozygous familial hypercholesterolemia
por: Parihar, Ravi Kumar, et al.
Publicado: (2012)

Homozygous Familial Hypercholesterolemia
por: Nohara, Atsushi, et al.
Publicado: (2021)

Two Novel Disease-Causing Mutations in the LDLR of Familial Hypercholesterolemia
por: Hu, Haochang, et al.
Publicado: (2021)

The Relationship Between Abdominal Body Composition and Metabolic Syndrome After a Weight Reduction Program in Adult Men with Obesity
por: Liao, Chun-Cheng, et al.
Publicado: (2020)

Two-hour post-challenge hyperglycemia, but not fasting plasma glucose, associated with severity of coronary artery disease in patients with angina
por: Fu, Chia-Po, et al.
Publicado: (2018)

Greater preclinical atherosclerosis in treated monogenic familial hypercholesterolemia vs. polygenic hypercholesterolemia
por: Sharifi, Mahtab, et al.
Publicado: (2017)

The burden of severe hypercholesterolemia and familial hypercholesterolemia in a population-based setting in the US
por: Saadatagah, Seyedmohammad, et al.
Publicado: (2022)

Prevalence of familial hypercholesterolemia in patients with premature myocardial infarction
por: Cui, Yuxia, et al.
Publicado: (2019)

Efficacy of Evolocumab in Monogenic vs Polygenic Hypercholesterolemia
por: Lee, Timothy, et al.
Publicado: (2019)

Treatment Inertia in Patients With Familial Hypercholesterolemia
por: Langer, Anatoly, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kk86innp73jb41ce5grjk8gc3l